West Coast Clinical Trials has named Melton Affrime senior vice president, research and development, to further develop their growing clinical research capabilities.
Affrime spent the last five years at ICON Development Solutions as chief scientific officer where he delivered cutting edge translational medicine drug development programs.
“Affrime’s wealth of experience and industry knowledge has already made him a key addition to the WCCT family. We view his appointment as a sign of our commitment to being the leading company in our industry. There is increasing demand from our customers to design phase I studies with multiple endpoints and integrate development plans with a global focus,” said Kenneth Kim, CEO of WCCT.